14th Jul 2021 8:04 am |
RNS |
AIM Schedule 1 update by Poolbeg Pharma plc |
14th Jul 2021 7:01 am |
RNS |
New Contract win for Open Orphan’s Breda office |
14th Jul 2021 7:00 am |
RNS |
COVID-19 Human Challenge Programme update |
9th Jul 2021 7:00 am |
RNS |
HRV and Flu contract |
7th Jul 2021 4:41 pm |
RNS |
Second Price Monitoring Extn |
7th Jul 2021 4:36 pm |
RNS |
Price Monitoring Extension |
30th Jun 2021 7:00 am |
RNS |
2020 Annual Report and 2021 AGM Notice |
17th Jun 2021 7:00 am |
RNS |
Final Results to 31 December 2020 |
17th Jun 2021 7:00 am |
RNS |
Demerger Update |
14th Jun 2021 7:00 am |
RNS |
Re. Distribution in Specie and Notice of Results |
11th Jun 2021 7:00 am |
RNS |
Exercise of Warrants |
19th May 2021 7:00 am |
RNS |
Court Approval |
10th May 2021 7:15 am |
RNS |
Exercise of Share Options |
10th May 2021 7:00 am |
RNS |
£3m COVID challenge virus manufacturing contract |
29th Apr 2021 11:39 am |
RNS |
Result of General Meeting |
13th Apr 2021 7:00 am |
RNS |
Potential demerger of certain non-core assets |
9th Apr 2021 7:00 am |
RNS |
Launch of Disease in Motion platform |
31st Mar 2021 7:00 am |
RNS |
Holding(s) in Company |
26th Mar 2021 7:00 am |
RNS |
£7.5m Human Challenge Study Contract |
25th Mar 2021 7:00 am |
RNS |
COVID-19 Human Challenge Programme update |
11th Mar 2021 7:00 am |
RNS |
Journal for Clinical Studies article publication |
9th Mar 2021 7:00 am |
RNS |
New contract win with Oxford BioTherapeutics |
26th Feb 2021 4:58 pm |
RNS |
Holding(s) in Company |
17th Feb 2021 9:00 am |
RNS |
Ethics approval - COVID-19 Human Challenge Study |
9th Feb 2021 3:57 pm |
RNS |
Holding(s) in Company |
3rd Feb 2021 7:05 am |
RNS |
Exercise of Investor Warrants & TVR |
3rd Feb 2021 7:00 am |
RNS |
New challenge study quarantine clinic |
1st Feb 2021 7:00 am |
RNS |
Contract extension with Carna Biosciences |
21st Jan 2021 7:00 am |
RNS |
Article published in Drug Discovery Today |
20th Jan 2021 7:00 am |
RNS |
Expansion of volunteer recruitment centres |
11th Jan 2021 7:00 am |
RNS |
First volunteer dosed in COVID-19 clinical trial |
6th Jan 2021 4:29 pm |
RNS |
Holding(s) in Company |
6th Jan 2021 7:00 am |
RNS |
Contract renewal with top-3 pharmaceutical client |
31st Dec 2020 7:00 am |
RNS |
Rule 19.6(c) Confirmation |
23rd Dec 2020 7:00 am |
RNS |
Successful completion of toxicology study |
22nd Dec 2020 7:00 am |
RNS |
Contract renewal with top-3 pharmaceutical client |
14th Dec 2020 7:30 am |
RNS |
Exercise of Share Options |
14th Dec 2020 7:00 am |
RNS |
MHRA approval for nasal COVID-19 vaccine trial |
7th Dec 2020 7:00 am |
RNS |
Venn Life Sciences contract wins |
24th Nov 2020 7:00 am |
RNS |
Directors Change |